Cascade of Refusal—What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?

Ingrid T. Katz, David Bangsberg

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Recent recommendations by the World Health Organization support treatment for all people living with HIV (PLWH) globally to be initiated at the point of testing. While there has been marked success in efforts to identify and expand treatment for PLWH throughout sub-Saharan Africa, the goal of universal treatment may prove challenging to achieve. The pre-ART phase of the care cascade from HIV testing to HIV treatment initiation includes several social and structural barriers. One such barrier is antiretroviral therapy (ART) treatment refusal, a phenomenon in which HIV-infected individuals choose not to start treatment upon learning their ART eligibility. Our goal is to provide further understanding of why treatment-eligible adults may choose to present for HIV testing but not initiate ART when indicated. In this article, we will discuss factors driving pre-ART loss and present a framework for understanding the impact of decision-making on early losses in the care cascade, with a focus on ART refusal.

Original languageEnglish (US)
Pages (from-to)125-130
Number of pages6
JournalCurrent HIV/AIDS Reports
Volume13
Issue number2
DOIs
StatePublished - Apr 1 2016
Externally publishedYes

Fingerprint

Africa South of the Sahara
HIV
Therapeutics
Treatment Refusal
Decision Making
Learning

Keywords

  • Antiretroviral medications
  • ART refusal
  • Global epidemic
  • HIV prevention
  • HIV/AIDS
  • Point of testing
  • Review
  • Science of prevention
  • Treatment refusal

ASJC Scopus subject areas

  • Infectious Diseases
  • Virology

Cite this

Cascade of Refusal—What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa? / Katz, Ingrid T.; Bangsberg, David.

In: Current HIV/AIDS Reports, Vol. 13, No. 2, 01.04.2016, p. 125-130.

Research output: Contribution to journalReview article

@article{78e92d90961e456baaff934d51399f8e,
title = "Cascade of Refusal—What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?",
abstract = "Recent recommendations by the World Health Organization support treatment for all people living with HIV (PLWH) globally to be initiated at the point of testing. While there has been marked success in efforts to identify and expand treatment for PLWH throughout sub-Saharan Africa, the goal of universal treatment may prove challenging to achieve. The pre-ART phase of the care cascade from HIV testing to HIV treatment initiation includes several social and structural barriers. One such barrier is antiretroviral therapy (ART) treatment refusal, a phenomenon in which HIV-infected individuals choose not to start treatment upon learning their ART eligibility. Our goal is to provide further understanding of why treatment-eligible adults may choose to present for HIV testing but not initiate ART when indicated. In this article, we will discuss factors driving pre-ART loss and present a framework for understanding the impact of decision-making on early losses in the care cascade, with a focus on ART refusal.",
keywords = "Antiretroviral medications, ART refusal, Global epidemic, HIV prevention, HIV/AIDS, Point of testing, Review, Science of prevention, Treatment refusal",
author = "Katz, {Ingrid T.} and David Bangsberg",
year = "2016",
month = "4",
day = "1",
doi = "10.1007/s11904-016-0309-9",
language = "English (US)",
volume = "13",
pages = "125--130",
journal = "Current HIV/AIDS Reports",
issn = "1548-3568",
publisher = "Current Science, Inc.",
number = "2",

}

TY - JOUR

T1 - Cascade of Refusal—What Does It Mean for the Future of Treatment as Prevention in Sub-Saharan Africa?

AU - Katz, Ingrid T.

AU - Bangsberg, David

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Recent recommendations by the World Health Organization support treatment for all people living with HIV (PLWH) globally to be initiated at the point of testing. While there has been marked success in efforts to identify and expand treatment for PLWH throughout sub-Saharan Africa, the goal of universal treatment may prove challenging to achieve. The pre-ART phase of the care cascade from HIV testing to HIV treatment initiation includes several social and structural barriers. One such barrier is antiretroviral therapy (ART) treatment refusal, a phenomenon in which HIV-infected individuals choose not to start treatment upon learning their ART eligibility. Our goal is to provide further understanding of why treatment-eligible adults may choose to present for HIV testing but not initiate ART when indicated. In this article, we will discuss factors driving pre-ART loss and present a framework for understanding the impact of decision-making on early losses in the care cascade, with a focus on ART refusal.

AB - Recent recommendations by the World Health Organization support treatment for all people living with HIV (PLWH) globally to be initiated at the point of testing. While there has been marked success in efforts to identify and expand treatment for PLWH throughout sub-Saharan Africa, the goal of universal treatment may prove challenging to achieve. The pre-ART phase of the care cascade from HIV testing to HIV treatment initiation includes several social and structural barriers. One such barrier is antiretroviral therapy (ART) treatment refusal, a phenomenon in which HIV-infected individuals choose not to start treatment upon learning their ART eligibility. Our goal is to provide further understanding of why treatment-eligible adults may choose to present for HIV testing but not initiate ART when indicated. In this article, we will discuss factors driving pre-ART loss and present a framework for understanding the impact of decision-making on early losses in the care cascade, with a focus on ART refusal.

KW - Antiretroviral medications

KW - ART refusal

KW - Global epidemic

KW - HIV prevention

KW - HIV/AIDS

KW - Point of testing

KW - Review

KW - Science of prevention

KW - Treatment refusal

UR - http://www.scopus.com/inward/record.url?scp=84958767990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958767990&partnerID=8YFLogxK

U2 - 10.1007/s11904-016-0309-9

DO - 10.1007/s11904-016-0309-9

M3 - Review article

C2 - 26894487

AN - SCOPUS:84958767990

VL - 13

SP - 125

EP - 130

JO - Current HIV/AIDS Reports

JF - Current HIV/AIDS Reports

SN - 1548-3568

IS - 2

ER -